Invention Grant
- Patent Title: Recombinant modified vaccinia virus Ankara influenza vaccine
- Patent Title (中): 重组修饰牛痘病毒安卡拉流感疫苗
-
Application No.: US13877218Application Date: 2011-10-07
-
Publication No.: US09173933B2Publication Date: 2015-11-03
- Inventor: Josef Weigl , Jürgen Hausmann , Robin Steigerwald
- Applicant: Josef Weigl , Jürgen Hausmann , Robin Steigerwald
- Applicant Address: DK Kvistgaard
- Assignee: BAVARIAN NORDIC A/S
- Current Assignee: BAVARIAN NORDIC A/S
- Current Assignee Address: DK Kvistgaard
- Agency: Law Office of Salvatore Arrigo and Scott Lee, LLP
- Priority: EP11001749 20110302
- International Application: PCT/EP2011/004996 WO 20111007
- International Announcement: WO2012/048817 WO 20120419
- Main IPC: A61K39/275
- IPC: A61K39/275 ; A61K39/145 ; C12N15/86 ; A61K39/12 ; A61K39/00
Abstract:
The invention concerns a recombinant modified vaccinia virus Ankara (MVA virus) expressing at least two external influenza virus antigens and/or an epitope of one or more of the at least two antigens and at least two internal influenza virus antigens and/or an epitope of the at least two antigens. The invention, thus, concerns a recombinant MVA virus encoding multiple external and/or internal influenza virus antigens, preferably from multiple influenza virus strains. The invention further concerns the use of said recombinant MVA in preparing a medicament and vaccine for influenza virus. Further encompassed by the present invention are methods, composition and kits.
Public/Granted literature
- US20130183335A1 RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA INFLUENZA VACCINE Public/Granted day:2013-07-18
Information query
